Merck & Co., Inc. MRK delivered better than expected results for the third quarter. The company also updated its full year outlook, sending the stock higher in pre-market trading.
- Merck reported GAAP EPS of $0.78 and adjusted EPS of $1.07 and beat consensus by $0.08 a share.
- Generated $10.5 billion sales revenue and topped Street estimates by $0.356 billion.
- Narrowed and lifted full year EPS outlook to $2.02-$2.09 and adjusted EPS between $3.71 and $3.78.
- Similarly, revenue forecast has been narrowed and increased to $39.7-$40.2 billion.
- Street is looking for an EPS of $3.75 on revenue of $39.70 billion for the year 2016.
The stock gained 2.22 percent to $62.10 in pre-market trading.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in